Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07FCB
|
||||
| Former ID |
DNC007498
|
||||
| Drug Name |
4-phenyl-1-(1-phenylethyl)piperidin-4-ol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528785] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H23NO
|
||||
| Canonical SMILES |
CC(C1=CC=CC=C1)N2CCC(CC2)(C3=CC=CC=C3)O
|
||||
| InChI |
1S/C19H23NO/c1-16(17-8-4-2-5-9-17)20-14-12-19(21,13-15-20)18-10-6-3-7-11-18/h2-11,16,21H,12-15H2,1H3
|
||||
| InChIKey |
PKTJCXJTMHJHNK-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528785] | |
| Nociceptin receptor | Target Info | Inhibitor | [528785] | ||
| Kappa-type opioid receptor | Target Info | Inhibitor | [528785] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Opioid prodynorphin pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.